Analystreport

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com